If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.00    -0.015 (-1.48%)
Bid:
1.00
Ask:
1.05
Spread: 0.05 (5.00%)
Market Cap: £20.06m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Investor Presentation

20 Mar 2024 13:01

RNS Number : 6429H
Quadrise PLC
20 March 2024
 

20 March 2024

Quadrise Plc ("Quadrise" or the "Company")

Investor Presentation

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, will be hosting a meeting for investors presented by Chief Executive Officer, Jason Miles, and Chairman, Andy Morrison, to provide an update following the announcement of the Interim Results on 18 March 2024.

The presentation, hosted on Investor Meet Company, will take place at 11:00am GMT on Tuesday, 26 March 2024. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 25 March 2024, 09:00am GMT, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free through the following link:

https://www.investormeetcompany.com/quadrise-plc/register-investor.

Investors who already follow Quadrise Plc on the Investor Meet Company platform will automatically be invited.

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

Katy BirkinGeorge Lawson

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay ThomsonPeter Jacob

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR? emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEUFESELSEID
Date   Source Headline
11th Mar 20139:31 amRNSWembley Investor and Analyst Presentation
4th Mar 20133:13 pmRNSTotal Voting Rights
4th Mar 20133:07 pmRNSDirector/PDMR Shareholding
18th Feb 20137:00 amRNSHolding(s) in Company
14th Feb 20135:34 pmRNSHolding(s) in Company
13th Feb 201310:31 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSThird Quarter Interim Management Statement
4th Feb 20134:04 pmRNSTotal Voting Rights
4th Feb 20133:59 pmRNSDirector/PDMR Shareholding
29th Jan 20134:05 pmRNSHolding(s) in Company
25th Jan 201310:15 amRNSHolding(s) in Company
24th Jan 201310:17 amRNSHolding(s) in Company
16th Jan 20134:25 pmRNSHolding(s) in Company
9th Jan 20133:08 pmRNSDirector/PDMR Shareholding
14th Dec 201210:24 amRNSHolding(s) in Company
3rd Dec 201211:46 amRNSTotal Voting Rights
3rd Dec 201211:18 amRNSBlocklisting Interim Review
3rd Dec 201210:39 amRNSDirector/PDMR Shareholding
26th Nov 201210:03 amRNSHolding(s) in Company
26th Nov 20127:00 amRNSResults for the six months ended 30 September 2012
13th Nov 201211:51 amRNSNotice of Results
6th Nov 201212:19 pmRNSAdditional Listing
1st Nov 20121:22 pmRNSTotal Voting Rights
1st Nov 20121:15 pmRNSDirector/PDMR Shareholding
31st Oct 20125:42 pmRNSHolding(s) in Company
31st Oct 20124:19 pmRNSHolding(s) in Company
31st Oct 20124:17 pmRNSHolding(s) in Company
4th Oct 201212:30 pmRNSHolding(s) in Company
1st Oct 201210:17 amRNSTotal Voting Rights
1st Oct 201210:14 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSDirectorate Change
21st Sep 20128:37 amRNSHolding(s) in Company
11th Sep 20121:34 pmRNSDirector/PDMR Shareholding
31st Aug 20122:52 pmRNSTotal Voting Rights
31st Aug 20122:51 pmRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSInterim Management Statement
24th Jul 20127:00 amRNSAppointment of new Finance Director
23rd Jul 20123:05 pmRNSResult of AGM
23rd Jul 20122:27 pmRNSEGM Statement
20th Jul 20125:29 pmRNSDirector/PDMR Shareholding
16th Jul 20123:00 pmRNSWembley Analyst and Investor presentation
13th Jul 20123:33 pmRNSDirector/PDMR Shareholding
4th Jul 20128:00 amRNSNew joint venture with Hong Kong investor
2nd Jul 20122:07 pmRNSAnnual Information Update
25th Jun 201212:34 pmRNSAnnual Financial Report
25th Jun 201210:41 amRNSDirector/PDMR Shareholding
20th Jun 20122:43 pmRNSHolding(s) in Company
19th Jun 20121:56 pmRNSDirector/PDMR Shareholding
18th Jun 20127:01 amRNSJoint Venture to develop Greenwich Peninsula
12th Jun 20122:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.